Product
mRNA COVID-19 vaccine
3 clinical trials
3 indications
Indication
COVID-19Indication
Multiple SclerosisIndication
Infections during pregnancyClinical trial
Safety and Immunogenicity of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) as a Booster Following Primary Vaccination of Either Inactivated or mRNA or Viral Vector COVID-19 VaccinesStatus: Active (not recruiting), Estimated PCD: 2024-11-30
Clinical trial
An Open-label Multicenter Study to Assess Response to COVID-19 Vaccine in Participants With Multiple Sclerosis Treated With Ofatumumab 20 mg SubcutaneouslyStatus: Completed, Estimated PCD: 2023-04-14
Clinical trial
The Impact of COVID-19 on Maternal and Neonatal OutcomesStatus: Recruiting, Estimated PCD: 2025-05-05